The Case for PrEP
1. Early data in animal studies strongly suggest the strategy is effective.
2. Glaxo's Combivir is already prescribed to prevent infections in men who take it after unprotected sex with an HIV-positive partner.
3. Some 74% of participants in a 2009 survey of gay men said they would use PrEP if it were available.